These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11730700)

  • 1. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury.
    Sizonenko SV; Sirimanne ES; Williams CE; Gluckman PD
    Brain Res; 2001 Dec; 922(1):42-50. PubMed ID: 11730700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats.
    Guan J; Thomas GB; Lin H; Mathai S; Bachelor DC; George S; Gluckman PD
    Neuropharmacology; 2004 Nov; 47(6):892-903. PubMed ID: 15527823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats.
    Guan J; Waldvogel HJ; Faull RL; Gluckman PD; Williams CE
    Neuroscience; 1999 Mar; 89(3):649-59. PubMed ID: 10199602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intracerebroventricular application of insulin-like growth factor 1 and its N-terminal tripeptide on cerebral recovery following cardiac arrest in rats.
    Knapp J; Teschendorf P; Vogel P; Bruckner T; Böttiger BW; Popp E
    Resuscitation; 2013 May; 84(5):684-9. PubMed ID: 23103885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.
    Saura J; Curatolo L; Williams CE; Gatti S; Benatti L; Peeters C; Guan J; Dragunow M; Post C; Faull RL; Gluckman PD; Skinner SJ
    Neuroreport; 1999 Jan; 10(1):161-4. PubMed ID: 10094155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat.
    Svedin P; Guan J; Mathai S; Zhang R; Wang X; Gustavsson M; Hagberg H; Mallard C
    Dev Neurosci; 2007; 29(4-5):393-402. PubMed ID: 17762207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat.
    Baker AM; Batchelor DC; Thomas GB; Wen JY; Rafiee M; Lin H; Guan J
    Neuropeptides; 2005 Apr; 39(2):81-7. PubMed ID: 15752541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral transportation and cellular localisation of insulin-like growth factor-1 following central administration to rats with hypoxic-ischemic brain injury.
    Guan J; Beilharz EJ; Skinner SJ; Williams CE; Gluckman PD
    Brain Res; 2000 Jan; 853(2):163-73. PubMed ID: 10640614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.
    Guan J; Krishnamurthi R; Waldvogel HJ; Faull RL; Clark R; Gluckman P
    Brain Res; 2000 Mar; 859(2):286-92. PubMed ID: 10719076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
    Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
    Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment in animal models.
    Guan J; Bennet L; Gluckman PD; Gunn AJ
    Endocr Dev; 2005; 9():31-43. PubMed ID: 15879686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins.
    Guan J; Williams CE; Skinner SJ; Mallard EC; Gluckman PD
    Endocrinology; 1996 Mar; 137(3):893-8. PubMed ID: 8603600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPE and GPE analogues as promising neuroprotective agents.
    Cacciatore I; Cornacchia C; Baldassarre L; Fornasari E; Mollica A; Stefanucci A; Pinnen F
    Mini Rev Med Chem; 2012 Jan; 12(1):13-23. PubMed ID: 22070686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed IGF-1 treatment reduced long-term hypoxia-ischemia-induced brain damage and improved behavior recovery of immature rats.
    Zhong J; Zhao L; Du Y; Wei G; Yao WG; Lee WH
    Neurol Res; 2009 Jun; 31(5):483-9. PubMed ID: 19500451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats.
    Guan J; Miller OT; Waugh KM; McCarthy DC; Gluckman PD
    Neuroscience; 2001; 105(2):299-306. PubMed ID: 11672597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in inflammation is associated with the protective effect of Gly-Pro-Glu and cycloprolylglycine against Aβ-induced depletion of the hippocampal somatostatinergic system.
    Aguado-Llera D; Canelles S; Fernández-Mendívil C; Frago LM; Argente J; Arilla-Ferreiro E; López MG; Barrios V
    Neuropharmacology; 2019 Jun; 151():112-126. PubMed ID: 30981749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats.
    Batchelor DC; Lin H; Wen JY; Keven C; Van Zijl PL; Breier BH; Gluckman PD; Thomas GB
    Anal Biochem; 2003 Dec; 323(2):156-63. PubMed ID: 14656520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.
    Guan J; Gluckman PD
    Br J Pharmacol; 2009 Jul; 157(6):881-91. PubMed ID: 19438508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta?
    Brywe KG; Mallard C; Gustavsson M; Hedtjärn M; Leverin AL; Wang X; Blomgren K; Isgaard J; Hagberg H
    Eur J Neurosci; 2005 Mar; 21(6):1489-502. PubMed ID: 15845077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.